UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049902
Receipt number R000056836
Scientific Title Prospective and retrospective observational study on the outcome of treatment with various antimicrobial agents in Mycoplasma genitalium urethritis
Date of disclosure of the study information 2022/12/26
Last modified on 2022/12/26 14:21:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective and retrospective observational study on the outcome of treatment with various antimicrobial agents in Mycoplasma genitalium urethritis

Acronym

Study on the Outcome of Mycoplasma genitalium urethritis treatment

Scientific Title

Prospective and retrospective observational study on the outcome of treatment with various antimicrobial agents in Mycoplasma genitalium urethritis

Scientific Title:Acronym

Study on the Outcome of Mycoplasma genitalium urethritis treatment

Region

Japan


Condition

Condition

Mycoplasma genitalium urethritis

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to determine the clinical efficacy of various antimicrobial agents against Mycoplasma genitalium infections.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluate efficacy rates (effect on subjective symptoms, effect on pyuria, and bacteriological effect) and adverse events with various antimicrobial treatments.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

Patients diagnosed with nongonococcal urethritis
Patients who give consent to participate in this study

Key exclusion criteria

Patients who have refused to participate in this study by submitting a publicly available opt-out document

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name Mitsuru
Middle name
Last name Yasuda

Organization

Sapporo Medical University School of Medicine

Division name

Department of Infection Control & Laboratory Medicine

Zip code

060-8543

Address

S1 W16, Chuo-ku, Sapporo, Hokkaido

TEL

011-611-2111

Email

yasuda7jpe@sapmed.ac.jp


Public contact

Name of contact person

1st name Mitsuru
Middle name
Last name Yasuda

Organization

Sapporo Medical University School of Medicine

Division name

Department of Infection Control & Laboratory Medicine

Zip code

060-8543

Address

S1 W16, Chuo-ku, Sapporo, Hokkaido

TEL

011-611-2111

Homepage URL


Email

yasuda7jpe@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Sapporo Medical University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo Medical University School of Medicine

Address

S1 W17, Chuo-ku, Sapporo, Hokkaido

Tel

011-611-2111

Email

ji-rskk@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 09 Month 22 Day

Date of IRB

2022 Year 11 Month 10 Day

Anticipated trial start date

2022 Year 11 Month 10 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Compare treatment outcomes with a single oral dose of azithromycin 1g, the standard of care.


Management information

Registered date

2022 Year 12 Month 26 Day

Last modified on

2022 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056836


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name